Detalhe da pesquisa
1.
Emerging monoclonal antibody therapy for head and neck squamous cell carcinoma.
Expert Opin Emerg Drugs
; : 1-12, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38616696
2.
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
N Engl J Med
; 380(12): 1116-1127, 2019 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30779529
3.
The pharmacokinetic and safety profile of single-dose deferiprone in subjects with sickle cell disease.
Ann Hematol
; 101(3): 533-539, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34981144
4.
Emerging drugs for the treatment of sickle cell disease: a review of phase II/III trials.
Expert Opin Emerg Drugs
; 27(2): 211-224, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35912835
5.
Use of midostaurin in mixed phenotype acute leukemia with FLT3 mutation: A case series.
Eur J Haematol
; 108(2): 163-165, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34653270
6.
Implementing DPYD*2A Genotyping in Clinical Practice: The Quebec, Canada, Experience.
Oncologist
; 26(4): e597-e602, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33274825
7.
Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer.
Mod Pathol
; 34(3): 532-541, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33239737
8.
Effect of mannitol on acute kidney injury induced by cisplatin.
Support Care Cancer
; 29(4): 2083-2091, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32862356
9.
Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial.
Lancet Oncol
; 21(12): 1563-1573, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33284113
10.
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study.
Lancet
; 393(10167): 156-167, 2019 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30509740
11.
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.
Lancet
; 394(10212): 1915-1928, 2019 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31679945
12.
Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise Centers.
Oncologist
; 25(10): e1509-e1515, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32735386
13.
Contemporary North-American population-based validation of the International Germ Cell Consensus Classification for metastatic germ cell tumors of the testis.
World J Urol
; 38(6): 1535-1544, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31463562
14.
Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma.
BMC Cancer
; 19(1): 68, 2019 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30642290
15.
Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract.
World J Urol
; 37(7): 1329-1337, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30298285
16.
Development and Implementation of a Continuing Medical Education Program in Canada: Knowledge Translation for Renal Cell Carcinoma (KT4RCC).
J Cancer Educ
; 34(1): 14-18, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28779441
17.
North American population-based validation of the National Comprehensive Cancer Network Practice Guideline Recommendations for locoregional lymph node and bone imaging in prostate cancer patients.
Br J Cancer
; 119(12): 1552-1556, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30425350
18.
Liver Iron Quantification with MR Imaging: A Primer for Radiologists.
Radiographics
; 38(2): 392-412, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29528818
19.
Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial.
Lancet Oncol
; 18(3): 323-335, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28131786
20.
Aetiological heterogeneity of head and neck squamous cell carcinomas: the role of human papillomavirus infections, smoking and alcohol.
Carcinogenesis
; 38(12): 1188-1195, 2017 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29029021